As CPRIT continues to ease its way back into the business of granting high-value funding to biotech businesses in search of resources to research and develop new cancer treatments, the organization still appears to be focused on assuring that the review and oversight process for awards in the commercial sphere are properly administrated. As a result, CPRIT has announced the hiring of another executive who will specifically oversee the award process for businesses seeking state funds for cancer research in Texas, along with the new oversight established by the Texas legislature and signed into law by Governor Rick Perry.
CPRIT has announced that Dr. Thomas Goodman will function as the organization’s chief product development officer. In effect, he will assume the same role as his predecessor, Jerald “Jerry” Cobbs, who has been the only principal involved in the CPRIT scandal to be indicted for Peloton’s improper award, which led to a funding freeze, investigation, and reform of the organization. However, together with substantially stricter guidelines in the review and funding process for biotech companies, Dr. Goodman will have a more transparent framework to work with.
According to a recent news release, Dr. Goodman, has a background in science, having earned a Ph.D. in biochemistry from the University of Wisconsin as well as a master’s degree in business administration from the University of California, Berkeley. Priot to his new role at CPRIT, which will begin effective April 14th,he worked at Arizona Technology Enterprises, which is an organization that works with University of Arizona researchers to commercialize their research findings. CPRIT has reported that his annual salary will be $215,000.